Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Creo Medical (CREO)

Price 34.50p on 18-04-2024 at 10:00:03
Change 0.00p 0%
Buy 35.00p
Sell 34.00p
Buy / Sell CREO Shares
Last Trade: Sell 14,525.00 at 34.34p
Day's Volume: 55,398
Last Close: 34.50p
Open: 34.50p
ISIN: GB00BZ1BLL44
Day's Range 34.50p - 34.50p
52wk Range: 23.25p - 49.00p
Market Capitalisation: £125m
VWAP: 34.29447p
Shares in Issue: 361m

Recent Trades History Creo Medical (CREO)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 14,525 34.34p Ordinary
09:43:21 - 18-Apr-24
Sell* 5,500 34.34p Ordinary
08:40:55 - 18-Apr-24
Buy* 500 34.85p Ordinary
08:25:44 - 18-Apr-24
Sell* 2,500 34.265p Ordinary
07:04:15 - 18-Apr-24
Sell* 32,373 34.26p Negotiated Trade
07:03:51 - 18-Apr-24

Share Price History for Creo Medical

Time period:
to
Date Open High Low Close Volume

Share News for Creo Medical

EARNINGS AND TRADING: Dar Global celebrates "outstanding" year

1st Mar 2024 13:34

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Creo Medical makes "considerable strides" toward 2025 break-even goal

7th Feb 2024 10:54

(Alliance News) - Creo Medical Group PLC on Wednesday said that cost controls and new product sales had supported strong growth in 2023, as the company said it is on track to achieve cash flow break-even by 2025. Read More

IN BRIEF: Creo Medical partners with Khalifa University in Abu Dhabi

5th Feb 2024 12:11

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Will collaborate with Khalifa University of Science & Technology in Abu Dhabi. Says partnership has an initial focus on healthcare challenges relevant to the population in the United Arab Emirates, as well as the wider Middle East and North Africa region. Chief Executive Officer Craig Gulliford says: "As part of our strategy, we are driven to exploit our IP either directly or in partnership with third-parties, as shown by our robotic assisted surgery collaborations. Khalifa University is a research-intensive organisation with a similar drive to develop and commercially exploit leading technologies, at scale and on a global basis. The combination of Creo's people, technology and IP with Khalifa University's teams, technologies, facilities and resources represents a great opportunity for both organisations to advance and commercialise incremental technology and products and enhance research profiles internationally." Read More

TRADING UPDATES: Creo unveils product in APAC; Unilever hires director

31st Jan 2024 18:15

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Creo Medical's Speedboat UlstraSlim device used in Latin America

10th Jan 2024 12:32

(Alliance News) - Creo Medical Group PLC on Wednesday said its Speedboat UltraSlim device has been used successfully in Latin America for the first time. Read More

FTSE 100 Latest
Value7,859.24
Change11.25

Login to your account

Forgot Password?

Not Registered